Successful Surgery At Cyanamid

'Watch the stock of American Cyanamid pop from here on." That's what one New York money manager says now that word of Cyanamid's conversion into a medical-products company is starting to spread. Cyanamid's program to divest most of its chemical operations is well on its way. On Oct. 24, Standard & Poor's reclassified Cyanamid by moving its stock, now selling at 64, from Diversified Chemicals to Diversified Health Care.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.